Craig Shimasaki, PhD, MBA

Dr. Craig Shimasaki holds a BS in Biochemistry, UC Davis, a PhD in Molecular Biology, Univ of Tulsa, an MBA at Northwestern Univ. He is Adjunct Prof at OU and co-founder/CEO of Moleculera Biosciences, a neuroimmunology precision-medicine company focused on identifying and treating underlying causes of neuropsychiatric and behavioral disorders. Starting at Genentech, he has over 40 years of experience in molecular biology, viral pathogenesis, and infection-triggered autoimmune neuropsychiatric disorders.